Morgan Stanley maintains Everest Group at Equal-Weight, raises price target to $425 from $395

Morgan Stanley kept its 'Equal-Weight' rating on Everest Group but raised its price target to $425 from $395, suggesting a 1.8% downside from the Nov 16 close of $433. Recent analyst price targets for Everest Group range from $419 to $450.

Original reporting
Published Nov 17, 2026, 4:02 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 17, 2026, 4:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains Everest Group at Equal-Weight, raises price target to $425 from $395 — source image
Decision brief

The 30-second read

$EGNeutralLow
01

Why it matters

A higher price target can influence sentiment and options positioning, but the lack of a rating change and absence of new company-specific information reduces trading urgency.

02

Market read

This is incremental sell-side information for EG, with the article quantifying only a small implied downside versus the Nov 16 close.

03

What to watch

Traders may already have priced in recent analyst target dispersion ($419 to $450); without new fundamentals, follow-through may be limited.

Relevance 4/10Novelty 4/10Timing: as of the analyst note publication date, for positioning around incremental target changes

Background

The article summarizes a Morgan Stanley analyst action on Everest Group, including a maintained rating and an updated price target.

Company-level read

Ticker impact

$EGNeutralMedium confidence
Context

Morgan Stanley maintained Everest Group at Equal-Weight and raised its price target to $425 from $395, implying modest downside versus the Nov 16 close.

Expected impact

Likely modest support or limited upside as the market weighs a higher target against the still-small implied downside.

Evidence & confidence

This is an analyst note update (PT change) without new company fundamentals; the article also quantifies only a small implied downside from the prior close, limiting expected repricing.

Market effects

Minimal, since it is a single-name analyst target change with no sector-wide catalyst described.

None indicated.

None indicated.

Counterpoint

The Equal-Weight reiteration and small implied downside suggest the PT raise may not change near-term expectations meaningfully.

Key entities

  • Everest Group

    Subject of the analyst action: Equal-Weight maintained, price target raised to $425 from $395.

  • Morgan Stanley

    Issued the maintained rating and raised price target referenced in the article.

Related articles

$EGMedAI 8/10

Everest Group 3Q 2026: Revenue $3.71B, EPS $6.12— 10-Q Summary

Everest Group reported 3Q 2026 revenue of $3.71B, down 14% YoY, and net income of $233M, down 8.9% YoY. Diluted EPS rose slightly to $6.12. Nine-month premiums earned fell 12.6% to $10.2B, with declines in Reinsurance Treaty and Legacy volumes. The company focused on Reinsurance Treaty and Global Wholesale & Specialty, and launched Annapurna Re. Sales of Canadian, Colombian, and Mexican operations are planned.

$EGMed

Everest To Sell Chile Insurance Unit To AIG

Everest Group (EG) is selling its Chile insurance unit to AIG, marking its final planned divestiture in Latin America. The deal is expected to close in the first half of 2027. Everest's shares rose 2.40% to $410.21, while AIG's shares gained 0.14% to $81.55 on NYSE.

$EGMed

Everest Agrees to Sell Chile Insurance to AIG

Everest Group (NYSE: EG) agreed to sell its Chile insurance business to AIG (NYSE: AIG), completing its exit from Latin American commercial retail insurance. The sale follows the recent completion of Everest's Colombia insurance business sale to AIG. The Chile deal is expected to close in the first half of 2027, pending regulatory approvals.

$EGMed

What Everest Group (EG) Said on Its Q3 Earnings Call

Everest Group reported Q3 earnings, highlighting a $600M increase in casualty reserves, with 2/3 tied to North American business. Reinsurance premiums fell 6% YoY. The company's Global Wholesale & Specialty segment saw 3% premium growth and improved margins. Everest repurchased 1.3M shares and returned $550M to shareholders. Management expects continued competition in catastrophe reinsurance and remains selective in casualty.